Understanding and countering anti-microbial drug resistance (AMR).

 The Biotech Institute uses sequencing-based  innovative technologies to decipher the molecular causes and mechanisms of AMR, including the big problem of co-infections. Our research assists in developing appropriate strategies to enable medical practitioners to provide more informed therapeutic decisions and provides a solid framework for comprehensive AMR stewardship programs. One of our current efforts is to disentangle the effects of the COVID-19 pandemic from the 'classical' AMR problem.

Innovative tools for genome regulation

In this project, we aim to develop molecular biotechnology and genomic tools that can be used as biological drugs (biologics) to counteract disease. Such tools can also be employed to increase the productivity of animals and crops, reduce chemical usage in agriculture (e.g. through bio-fertilizers), and provide means to better respond to climate change and ensure food security.